Format

Send to

Choose Destination
Am J Med. 2019 Jul;132(7):e622. doi: 10.1016/j.amjmed.2019.03.004.

The Reply.

Author information

1
Université de Bordeaux, Institute National de la Santé Et de la Recherche Médicale (INSERM), Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, Bordeaux, France.
2
Université de Bordeaux, Institute National de la Santé Et de la Recherche Médicale (INSERM), Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, Bordeaux, France; Centre Hospitalier Universitaire de Bordeaux, France; Bordeaux PharmacoEpi, INSERM Centre d'Investigation Clinique (CIC), 1401, Bordeaux, France.
3
FACT (French Alliance for Cardiovascular Clinical Trials), DHU FIRE, University Paris Diderot, AP-HP, INSERM U-1148, Paris, France; National Heart and Lung Institute, Institute of Cardiovascular Medicine and Science, Royal Brompton Hospital, Imperial College, London, United Kingdom.
4
Université de Bordeaux, Institute National de la Santé Et de la Recherche Médicale (INSERM), Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, Bordeaux, France; Centre Hospitalier Universitaire de Bordeaux, France.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center